NCT04492163View on ClinicalTrials.gov

Open-Label Pilot Study of OPTUNE® With High Density Transducer Arrays for the Treatment of Recurrent GBM

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

July 14, 2020

Primary Completion Date

June 20, 2023

Study Completion Date

June 20, 2023

Conditions
Glioblastoma Multiforme
Interventions
DEVICE

TTFields

"TTFields treatment will consist of wearing four electrically insulated electrode arrays on the head. The treatment enables the patient to maintain regular daily routine.~Other Names:~• TTFields"

Trial Locations (1)

150 30

Nemocnice Na Homolce, Prague

All Listed Sponsors
lead

NovoCure GmbH

INDUSTRY

NCT04492163 - Open-Label Pilot Study of OPTUNE® With High Density Transducer Arrays for the Treatment of Recurrent GBM | Biotech Hunter | Biotech Hunter